← Back to patent-cliff list
EOM147
Tier C — Watch / tradeEOM147
EOM Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CaM, FGFRs, PDGFR, VEGFR
Indications (approved)：黄斑水肿, 湿性年龄相关性黄斑变性, Diabetic retinopathy
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of EOM147?
Approved indications include: 黄斑水肿, 湿性年龄相关性黄斑变性, Diabetic retinopathy.
When does the EOM147 patent expire?
No public expiry year is available for EOM147 yet; this page updates once verified.
How do I get a quote for EOM147 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01